Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A year into the pandemic, the FDA, CDC and USDA say there’s no credible evidence linking food or packaging to COVID-19.
The public can watch the proceedings on the FDA website and the agency’s YouTube, Facebook and Twitter channels.
Lower doses of some cancer drugs might be just as effective and less risky than what is currently prescribed by doctors.
The latest drugs approved by the Food and Drug Administration include one for non-small-cell lung cancer and acute myeloid leukemia.
Pfizer/BioNTech’s coronavirus vaccine is 95% effective for preventing symptomatic illness.
In the United States, an FDA expert advisory panel voted on December 10 to recommend emergency use authorization.
With the first vaccines expected within weeks, a CDC advisory panel votes on how to prioritize access.
Moderna has requested emergency use authorization for its mRNA vaccine candidate.
The drug is approved for adults and children with relapsed or refractory neuroblastoma in the bone or bone marrow.
Agency grants emergency authorization for antibody cocktail given to President Trump.
Upcoming hearing on the Pfizer/BioNTech vaccine will be livestreamed on YouTube, Facebook and Twitter.
Arthritis drug Olumiant (baricitinib) can be used in combination with remdesivir.
The new test kit, available by prescription, uses a self-collected nasal swab sample.
The blood test identifies biomarkers that could make patients eligible for targeted therapies.
The Food and Drug Administration re-emphasizes that mammography is still the most effective breast cancer screening test.
“Even though the tests have been around for a while, we don’t know how useful they’re really going to be in the clinical setting."
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.